Home > Products > Enzymatically Cleavable Linkers for Antibody-Drug Conjugates (ADCs)

Enzymatically Cleavable Linkers for Antibody-Drug Conjugates (ADCs)

Enzymatically Cleavable Linkers for Antibody-Drug Conjugates (ADCs)

Products

Advantages

• Contain Val-Cit sequence degradable by a lysosome enzyme
• Have superior plasma stability comparable to that of non-cleavable linkers
• Available for manufacturing with several tens gram scale


Application

Cathepsin B in the lysosome cleaves the peptide bond between Cit-PAB of dipeptide linkers containing valine (Val)-citrulline (Cit) and p-aminobenzylalcohol (PAB). When PAB and a drug are binded covalently with carbamate bonds, the drug can be released by hydrolysis after cleavage of the peptide bond between Cit-PAB. Antibody-drug conjugates (ADCs) has been developed using this mechanism.